Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone - Charbonnel, B; Karasik, A; Liu, J (Diabetes Care, 2006)
et al.